In the context of cancer, hematocrit levels can be a significant indicator of a patient's well-being and response to treatment. Abnormal hematocrit levels can signal various complications associated with cancer, such as internal bleeding, bone marrow issues, and the effects of chemotherapy or radiation therapy. Monitoring hematocrit can help healthcare providers make informed decisions regarding treatment adjustments and supportive care.
